LB Pharmaceuticals Inc
Pharmaceutical company · New York, United States · Nasdaq: LBRX
LB Pharmaceuticals Inc is a pharmaceutical company headquartered in New York, United States. Its earliest recorded incorporation is in 2015. Its shares trade on Nasdaq under the ticker LBRX. It has reported private securities offerings to the US SEC, most recently $111 million sold in a notice filed in 2024.
LB Pharmaceuticals at a glance
What does LB Pharmaceuticals do?
Private fundraising reported to the SEC
11 Form D notices; the most recent reported $110.7 million sold (2024).
Frequently asked questions about LB Pharmaceuticals
Where is LB Pharmaceuticals headquartered?
LB Pharmaceuticals Inc is headquartered in New York, United States.
What does LB Pharmaceuticals do?
LB Pharmaceuticals Inc is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is LB Pharmaceuticals a public company?
Yes. LB Pharmaceuticals Inc trades on Nasdaq under the ticker LBRX.
When was LB Pharmaceuticals founded?
The earliest incorporation on record for LB Pharmaceuticals Inc is in 2015, according to public company registers.
Similar companies
- SchrodingerNew York City, New York, United States
- Pfizer IncNew York City, New York, United States
- Actinium Pharmaceuticals, Inc.New York City, New York, United States
- Rocket Pharmaceuticals, Inc.New York City, New York, United States
- Progenics Pharmaceuticals IncNew York City, New York, United States
- Syndax Pharmaceuticals IncNew York City, New York, United States
- Nuvation Bio Inc.New York City, New York, United States
- Immunic, Inc.New York City, New York, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences